Background illustration for clinical trials search

Paid Clinical Trials Glenview

Discover 2,388 paid clinical trials in Glenview, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

for
Hypertension, Acute Severe Hypertension, Hypertensive Emergency,
Location: Chicago IL, Detroit MI, Beavercreek OH, Cleveland OH,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07511361

Phase 2, Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Chicago IL, Madison WI, Indianapolis IN, Ann Arbor MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase 1, Recruiting
Active & Responsive

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

for
Ductal Carcinoma in Situ
Location: Chicago IL, Saint Paul MN, Minneapolis MN,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: Female

Age: 18+

Code: NCT06075953

Phase 2, Recruiting
Active & Responsive

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Chicago IL, Indianapolis IN, Flint MI, Columbia OH,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase 2, Recruiting
Active & Responsive

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

for
Schizophrenia Spectrum and Other Psychotic Disorders,
Location: Chicago IL, Athens GA, Hartford CT, Dallas TX,
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 18 - 40

Code: NCT06740383

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

for
Cesarean Delivery, General Anesthesia
Location: Chicago IL, Indianapolis IN, Iowa City IA,
Sponsor: Yale University

Sex: Female

Age: 15 - 55

Code: NCT06030063

Recruiting
Active & Responsive

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

for
HER2-positive Metastatic Breast Cancer
Location: Chicago IL, Orland Park IL, New Lenox IL,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06551116

Recruiting
Active & Responsive

A Study of PHST001 in Advanced Solid Tumors

for
Advanced Solid Tumors, Ovarian Cancer, Endometrial Cancer,
Location: Chicago IL, Grand Rapids MI, Ann Arbor MI, Denver CO,
Sponsor: Pheast Therapeutics

Sex: All

Age: 18+

Code: NCT06840886

Phase 1, Recruiting
Active & Responsive

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for
Carcinoma, Non-Small-Cell Lung
Location: Chicago IL, Peoria IL, Indianapolis IN, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06623422

Phase 3, Recruiting
Active & Responsive

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Chicago IL, Milwaukee WI, Iowa City IA, Ann Arbor MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07101328

Phase 1, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: Chicago IL, Indianapolis IN, Columbus OH, Fargo ND,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase 3, Recruiting
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: Chicago IL, Indianapolis IN, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

for
FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Location: Chicago IL, New York NY, Boston MA, Houston TX,
Sponsor: Elevar Therapeutics

Sex: All

Age: 18+

Code: NCT07359820

Phase 2, Recruiting
Active & Responsive

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

for
Bladder Cancer
Location: Chicago IL, Cleveland OH, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07232602

Phase 1, Phase 2, Recruiting
Active & Responsive

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

for
Short Bowel Syndrome
Location: Chicago IL, St Louis MO, Nashville TN, Pittsburgh PA,
Sponsor: Zealand Pharma

Sex: All

Age: 18 - 70+

Code: NCT07197944

Phase 3, Recruiting
Active & Responsive

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

for
Type I Diabetes
Location: Chicago IL, Birmingham AL, Aurora CO, Renton WA,
Sponsor: Op-T LLC

Sex: All

Age: 18 - 50

Code: NCT06964087

Phase 2, Recruiting
Active & Responsive

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Chicago IL, Detroit MI, St Louis MO, Nashville TN,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 12+

Code: NCT05533697

Phase 1, Phase 2, Recruiting
Active & Responsive

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for
Non-small Cell Lung Cancer, NSCLC
Location: Chicago IL, Ypsilanti MI, Minneapolis MN, Kitchener,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06422143

Phase 3, Recruiting
Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for
Ovarian Cancer, Fallopian Tube Cancer
Location: Chicago IL, St Louis MO, Rochester MN, Durham NC,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting
Active & Responsive

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Chicago IL, Madison WI, Pittsburgh PA, Toronto,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 65

Code: NCT04786262

Phase 3, Recruiting